How a 340B successor might arise from the drug price negotiations
The 340B drug discount program requires manufacturers to sell drugs to safety-net hospitals at deep discounts, so they can reinvest the savings into care for low-income and uninsured patients. Despite its original intent, recent meteoric growth in this program has attracted considerable attention from various sectors. The Trump administration is currently on its second attempt […]